Fundraising FoxEmboMedics
Maple Grove, US · Founded 2012 · Delaware corporation
Find your way into EmboMedics
Sign up to see every warm intro you have to EmboMedics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EmboMedics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EmboMedics was founded in 2012 by Jafar Golzarian.
JG
Jafar GolzarianFounder
JF
Jon FreemanExecutive
LW
Lihui WengNamed on SEC filing
OS
Omid SouresrafilNamed on SEC filing
Board
GD
Gerald D. Van EeckhoutBoard director
RM
Reza MalekBoard director
RH
Robert HalversonBoard director
Reported raises · per SEC filings
Form D private placements$5.9M disclosed across 3 rounds · 2013–2016
▶$740.8KraisedOct 2017 · 12 investors · BiotechnologyRule 506(b)
▶$740.8KraisedOct 2017 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jafar GolzarianDirector, Promoter
- Robert CohenExecutive Officer, Director
- Robert HalversonDirector
- Gerald D. Van EeckhoutDirector
- Reza MalekDirector
- Offering amount
- $1.3M
- Amount sold
- $740.8K
- Proceeds to insiders
- $30K
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$4.3MraisedApr 2016 · 29 investors · BiotechnologyRule 506(b)
▶$4.3MraisedApr 2016 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lihui WengExecutive Officer
- Gerald D. Van EeckhoutDirector
- Reza MalekDirector
- Robert HalversonDirector
- Jon FreemanExecutive Officer
- Omid SouresrafilExecutive Officer, Director, Promoter
- Jafar GolzarianExecutive Officer, Director, Promoter
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$860KraisedFeb 2014 · 15 investors · BiotechnologyRule 506(b)
▶$860KraisedFeb 2014 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lihui WengExecutive Officer
- Omid SouresrafilExecutive Officer, Director, Promoter
- Jafar GolzarianExecutive Officer, Director, Promoter
- Reza MalekDirector
- Offering amount
- $860K
- Amount sold
- $860K
- First sale
- Jun 2013
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2017 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded EmboMedics?
- EmboMedics was founded by Jafar Golzarian in 2012.
- How much funding has EmboMedics raised?
- EmboMedics has disclosed $5.9M raised across 3 rounds.
- Where is EmboMedics headquartered?
- EmboMedics is headquartered in Maple Grove, US.